Lipidomics Market: By Type, By Lipid Source, By Application, and Geography.

Lipidomics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Blood Sample, Tissue Sample, and Others), By Lipid Source (Human Source, Animal Source, and Plant Source), By Application (Drug Discovery, Biomarker Discovery, Personalized Medicine, Diagnosis and Treatment, and Others), and Region.

Lipidomics Market size was valued at US$ 50.0 million in 2022 and is expanded to grow at a significant CAGR of 8.0% from 2023-2029. Lipidomics is a growing field of biomedical study that encompasses lipidome analysis. It's a complete and quantitative description of a collection of lipid species found in an organism. The worldwide lipidomics market is predicted to benefit from a wide range of lipidomics applications, as well as an increase in the prevalence of target diseases such as malignancies and the breadth of clinical trials and toxicological investigations. During the forecast period, the Lipidomics market is expected to rise rapidly. Novel technology approvals, as well as other organic growth tactics such as patents and events, are being prioritized by a lot of companies. Acquisitions, as well as collaborations and partnerships, were considered inorganic growth tactics in the market. These activities have paved the way for the expansion of business and the customer base of market players. The rise in the need for precise illness diagnosis, demand for tailored therapy, and technological breakthroughs in lipidomics are propelling the lipidomics market forward. Growth is attributed to meeting the requirements of aging populations and infants, and the prevalence of chronic diseases and changing food habits contribute to the intake of supplements and energy-providing food are boosting the global lipidomics market. In the forecast period of 2023-2029, rising raw material and technology costs are expected to pose a challenge to the lipid market. Over the anticipated period, the market is expected to rise due to an increase in the demand for precise illness diagnosis, growth in demand for personalized treatment, technological advancements in the field of lipidomics, and large investments from the public and commercial sectors in R&D activities.

Lipidomics Market Key Developments:
  • In July 2020, Croda International Plc (Croda) confirms that, following approval from the US regulatory authorities, it has now successfully completed the acquisition of Avanti Polar Lipids, Inc., a leader in drug delivery systems for next-generation pharmaceuticals.
  • In March 2020, Waters Corporation and the University of Tokyo are collaborating on a lipidomics research project to provide a clearer picture of what it means to be healthy. Led by Prof. Yoshiya Oda from the Graduate School of Medicine at the University of Tokyo, the study is exploring the relationship between lipids and human health through the application of ion mobility-mass spectrometry (IMS-MS) technology.  

Lipidomics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8%

Largest Market

North America

Fastest Growing Market

Asia-Pacific

Lipidomics Market Dynamics

The rise in the need for accurate illness diagnosis, demand for tailored therapy, and technological breakthroughs in lipidomics are propelling the lipidomics market forward. Increasing industrialization and growing health consciousness and awareness about the health benefits of lipids. However, the lipidomics market's growth is hampered by strict regulatory rules, a lack of modern instruments, a lack of technology acceptance, and a scarcity of experienced researchers

Lipidomics Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2022

US$ 50.0 million

Market CAGR

8%

By Sample Type

  • Blood Sample
  • Tissue Sample
  • Others

By Lipid Source

  • Human Source
  • Animal Source
  • Plant Source

By Application

  • Drug Discovery
  • Biomarker Discovery
  • Personalized Medicine
  • Diagnosis and treatment
  • Others

Key Features of the Report

  • The lipidomics market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

Frequently Asked Questions

The lipidomics market is projected to expand at a CAGR of 8.0% during the forecast period

Lipotype GmbH, Metabolon, Inc., Waters Corporation, Creative Proteomics, Thermo Fisher Scientific, MetaSysX

North America is the fastest-growing region for lipidomics market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Lipidomics Market Introduction 
2.1.Global Lipidomics Market  - Taxonomy
2.2.Global Lipidomics Market  - Definitions
2.2.1.By Sample Type
2.2.2.By Lipid Source
2.2.3.By Application
2.2.4.Region
3. Global Lipidomics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Lipidomics Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Lipidomics Market  By By Sample Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Blood Sample
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Tissue Sample
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Global Lipidomics Market  By By Lipid Source, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Human Source
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Animal Source
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Plant Source
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Global Lipidomics Market  By By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Drug Discovery
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Biomarker Discovery
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Personalized Medicine
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Diagnosis and Treatment
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Others
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. Global Lipidomics Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Lipidomics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. By Sample Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Blood Sample
9.1.2.Tissue Sample
9.1.3.Others
9.2.  By Lipid Source Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Human Source
9.2.2.Animal Source
9.2.3.Plant Source
9.3.  By Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Drug Discovery
9.3.2.Biomarker Discovery
9.3.3.Personalized Medicine
9.3.4.Diagnosis and Treatment
9.3.5.Others
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Lipidomics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. By Sample Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Blood Sample
10.1.2.Tissue Sample
10.1.3.Others
10.2.  By Lipid Source Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Human Source
10.2.2.Animal Source
10.2.3.Plant Source
10.3.  By Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Drug Discovery
10.3.2.Biomarker Discovery
10.3.3.Personalized Medicine
10.3.4.Diagnosis and Treatment
10.3.5.Others
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
 
11. Asia Pacific (APAC) Lipidomics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. By Sample Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Blood Sample
11.1.2.Tissue Sample
11.1.3.Others
11.2.  By Lipid Source Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Human Source
11.2.2.Animal Source
11.2.3.Plant Source
11.3.  By Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Drug Discovery
11.3.2.Biomarker Discovery
11.3.3.Personalized Medicine
11.3.4.Diagnosis and Treatment
11.3.5.Others
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Lipidomics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. By Sample Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Blood Sample
12.1.2.Tissue Sample
12.1.3.Others
12.2.  By Lipid Source Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Human Source
12.2.2.Animal Source
12.2.3.Plant Source
12.3.  By Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Drug Discovery
12.3.2.Biomarker Discovery
12.3.3.Personalized Medicine
12.3.4.Diagnosis and Treatment
12.3.5.Others
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Lipidomics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. By Sample Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Blood Sample
13.1.2.Tissue Sample
13.1.3.Others
13.2.  By Lipid Source Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Human Source
13.2.2.Animal Source
13.2.3.Plant Source
13.3.  By Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Drug Discovery
13.3.2.Biomarker Discovery
13.3.3.Personalized Medicine
13.3.4.Diagnosis and Treatment
13.3.5.Others
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Zora Biosciences OY
14.2.2.Owl Metabolomics
14.2.3.Avanti Lipids Polar, Inc.
14.2.4.The Metabolomics Innovation Centre
14.2.5.Lipotype GmbH
14.2.6.Metabolon, Inc.
14.2.7.Waters Corporation
14.2.8.Creative Proteomics
14.2.9.Thermo Fisher Scientific
14.2.10.MetaSysX
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Zora Biosciences OY
  • Owl Metabolomics
  • Avanti Lipids Polar, Inc.
  • The Metabolomics Innovation Centre
  • Lipotype GmbH
  • Metabolon, Inc.
  • Waters Corporation
  • Creative Proteomics
  • Thermo Fisher Scientific
  • MetaSysX

Related Industry Reports